酮咯酸在扁桃体切除术和悬雍垂腭咽成形术患者中的使用
本研究评估成人扁桃体伴或不伴腺样体切除术或悬雍垂腭咽成形术后使用酮咯酸对术后出血率的影响,评估2013年至2018年间手术的18岁以上患者。结果显示两组术后出血率无显著差异(P=0.331),出血控制方法亦无显著差异。结论认为酮咯酸不增加术后出血率。证据等级4。
要点
- 成人扁桃体切除或UPPP术后使用酮咯酸,术后出血率与对照组无显著差异(P=0.331)。
- 出血控制方法在两组间也无显著差异。
- 证据等级为4,结论需结合研究设计解读。
核心结论
- 酮咯酸不增加成人扁桃体伴或不伴腺样体切除术或悬雍垂腭咽成形术患者的术后出血率。
研究设计与样本
- 评估2013年至2018年间接受扁桃体伴或不伴腺样体切除术和悬雍垂腭咽成形术的18岁以上成人患者,以确定出血率,出血率基于因出血主诉至急诊科就诊的患者评估。
主要发现
- 两组术后出血率无显著差异(P=0.331)。
- 两组出血控制方法无显著差异。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Postoperative pain for tonsillectomy with or without adenoidectomy or uvulopalatopharyngoplasty (UPPP) can be severe. Ketorolac is a nonsteroidal anti-inflammatory drug that can be administered for analgesia in these patients. In the literature, ketorolac has been associated with an increased risk of hemorrhage after tonsillectomy with or without adenoidectomy. Many other surgical fields have successfully utilized this medicine for postoperative pain control without increased incidence of hemorrhage. The goal of this study was to analyze the effectiveness of ketorolac after tonsillectomy with or without adenoidectomy or UPPP in adults on postoperative hemorrhage rates. METHODS: Adult patients older than 18 years of age who underwent tonsillectomy with or without adenoidectomy and UPPP between 2013 and 2018 were assessed to determine hemorrhage rates. Hemorrhage rates were assessed based on patients presenting to the emergency department with complaint of hemorrhage. RESULTS: There was no significant difference between groups in the postoperative hemorrhage rates (P = .331) or the method of hemorrhage control. CONCLUSION: Ketorolac did not increase postoperative hemorrhage rates in patients posttonsillectomy with or without adenoidectomy or UPPP. LEVEL OF EVIDENCE: 4 Laryngoscope, 130:876-879, 2020.
引用
- McClain K, Williams AM, Yaremchuk K, et al. Ketorolac usage in tonsillectomy and uvulopalatopharyngoplasty patients. Laryngoscope. 2019. PMID: 31145482. doi:10.1002/lary.28077
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。